Informational Call State Biomonitoring Meeting 02212024.pdf
PDF 187 KB Posted
- Opportunity number
- CDC-RFA-EH-24-0043
About this file
This document provides information on a notice of funding opportunity from the Centers for Disease Control and Prevention to support state biomonitoring programs. Eligible state public health laboratories may propose investigations focusing on assessing environmental chemical exposures disproportionately affecting communities. Applicants may conduct targeted investigations of a specific at-risk community or statewide population surveillance with emphasis on minority groups. Proposed activities include biomonitoring, enhancing laboratory capabilities, coordinating with partners, and reporting findings. The total award ceiling is $1.1 million per year over three years to support strategies assessing exposures and optional laboratory equipment. Letters of support, a ten-page narrative, and workplan are required. Anticipated notice of awards will be issued in August 2024. The funding opportunity is assigned to the CDC's Environmental Public Health and Emergency Response program under Assistance Listing Number 93.070.
Informational Call State Biomonitoring Meeting 02212024.pdf
View the file
Other files
| File | Type | Posted |
|---|---|---|
| CDC-RFA-EH-24-0043 NOFO Additional Questions.pdf | ||
| Foa_Content_of_CDC-RFA-EH-24-0043.pdf |
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
CDC-RFA-EH-24-0043 State Biomonitoring Programs:
Assessing Dispropor�onate Exposure to Environmental Chemicals among Communi�es
Informa�onal Call Ques�ons and Answers February 21, 2024, at 1:00 PM EST
Program Strategies
1. The descrip�on discusses states leveraging exis�ng capabili�es. Does this mean that a lab must have been conduc�ng biomonitoring already? We have the capabili�es (instruments, skills, CLIA lab), but will need to set up the specific biomonitoring methods and projects.
a. States with exis�ng capabili�es (instruments, skills, CLIA lab) are eligible to apply even if they have not previously conducted biomonitoring studies. You will be able to set-up biomonitoring specific methods during the period of performance.
2. When you say only 2 projects, is part C considered a separate project?
a. Part C is not considered a project or biomonitoring inves�ga�on. It is a separate request for laboratory equipment. “No more than 2 inves�ga�ons” applies to part A, B, or a combina�on of strategies A and B.
3. For the project narra�ve, 10 pages is very short! Is the workplan table included in the page limit?
a. The narra�ve length is 10 pages. No, the workplan table is not included in the 10 pages and can be submited as an atachment.
4. For strategy B, can a project's sampling strategy oversample more than one unequally affected group?
a. Yes
5. Should analytes come from the Na�onal Report on Human Exposure to Environmental Chemicals?
a. Yes, the Na�onal Report on Human Exposure to Environmental Chemicals is updated biannually. We are not aware of any an�cipated addi�ons to the chemicals in the report.
6. CDC stopped measuring some chemicals in the Na�onal Report on Human Exposure to Environmental Chemicals. Can we s�ll measure them?
a. Yes, but CDC may not have the method ac�ve and may not be able to provide support.
7. Where do capacity building and enhanced lab exper�se fit into these strategies (A and B)?
a. Labs can propose new biomonitoring methods for their proposed inves�ga�ons under strategies A and/or B, but method development and valida�on must be outlined and completed by 8/31/2025. This NOFO will expand the approach from previous itera�ons to include outreach and educa�on with the community.
8. For applicants who were previously funded, how much progress of previous awards should be discussed in the applica�on?
a. You can men�on the impact of previous studies in your narra�ve. There is a 10-page limit to the project narra�ve.
Leters of Support https://www.cdc.gov/exposurereport/index.html https://www.cdc.gov/exposurereport/index.html https://www.cdc.gov/exposurereport/index.html
9. Are the leters of support recommended or required to demonstrate collabora�ons?
a. 3 leters of support are required
10. Can the 3 leters of support be from internal partners, or do they need to be from external agencies?
a. Yes, the leters can be from internal and/or external partners who will support your inves�ga�ons.
11. Can you have more than 3 leters of supports?
a. Yes
Organiza�onal Capacity
12. Are the principal inves�gators (PIs) of these grants generally lab or non-lab people? Is there any preference?
a. In past applica�ons, PIs have been people associated with the laboratory, but we do not have a preference.
13. Can a non-profit apply in the capacity as a fiscal agent for the state DPH?
Budget
14. The grant ceiling is $1.1 million. Is this per year, or is this the total across all 3 years?
a. The ceiling is applied per year. However, the ceiling reflects funding of the op�onal strategy C in year 1. This will not be available in the following two funding cycles.
15. Is the ceiling for strategies A and B $900,000?
16. Is the budget scored?
a. No
Applica�on Process
17. There is no page limit for budget jus�fica�on/narra�ve, correct?
a. Correct
18. Can atachments other than those listed in the NOFO be submited to support the project narra�ve?
a. Yes
19. Will there be an opportunity to ask additional questions in the future? If so, how should these be routed?
a. Yes. Send program questions to Rebecca Hunt at jxq6@cdc.gov, send grant services questions to Randall Slaven at jlf0@cd.gov.
20. Is there an anticipated timeline for when Notice of Awards (NOAs) will go out?
a. Yes. We expect to send NOAs out in August.
21. Will you post the Q & As?
mailto:jxq6@cdc.gov mailto:jlf0@cd.gov
a. Yes, we will update the NOFO lis�ng on Grants.gov to include the Q & As. We suggest subscribing to the NOFO lis�ng so you are automa�cally alerted when updates are made.
File details come from the government source that posted it. Updated .